Manager TitleAgeSince
Chief Executive Officer - 2026-03-31
Chief Tech/Sci/R&D Officer - 2009-07-16
Director of Finance/CFO 60 2022-06-30
Director TitleAgeSince
Director/Board Member 58 2020-07-08
Chairman 68 2021-12-08
Director/Board Member 78 2004-08-31
Date Insider Type Main position Quantity % Market Cap. Importance
7/9/20 Tender

Chief Executive Officer

29,206 0.1196%
7/9/20 Tender

Chief Financial Officer

500 0.0020% -
7/9/20 Tender

Director

102,200 0.4187%
Change 5-day change 1-year change 3-year change Capi.($)
-.--%+2.84% - - 1.41M
-1.94%-2.79%-27.07%+2.04% 173B
-1.00%-2.69%-10.86%+14.37% 113B
-2.46%+1.05%-24.91%+5.06% 109B
+1.52%+0.41%-48.13%-10.00% 74.44B
+0.46%+4.13%+4.50%+70.97% 60.1B
+3.27%+7.25%+18.14%+67.16% 51.87B
-0.20%-1.92%-6.87%-30.93% 49.21B
-2.21%-2.58%-18.34%+19.72% 41.52B
-4.04%-3.80%+24.37%-0.73% 32.79B
Average -0.32%+0.62%-9.91%+15.30% 78.34B
Weighted average by Cap. -0.18%+0.42%-16.04%+12.48%
Logo TearLab Corporation
TearLab Corporation is an in-vitro diagnostic company. The Company has commercialized a tear testing platform, the TearLab Osmolarity System, which enables eye care practitioners to test for sensitive and specific biomarkers using nanoliters of tear film at the point-of-care. The Company, through its subsidiary TearLab Research, Inc., develops technologies to enable eye care practitioners to test a range of biomarkers (chemistries, metabolites, genes and proteins) at the point-of-care. Its product, the TearLab Osmolarity System, enables the measurement of tear osmolarity in the doctor's office. The TearLab Osmolarity System consists of approximately three components: the TearLab disposable, the TearLab Pen, and the TearLab Reader. The TearLab disposable is a single-use microfluidic microchip. The TearLab Pen is a hand-held device that interfaces with the TearLab disposable. The TearLab Reader is a small desktop unit that allows for the docking of the TearLab Pen.
Employees
-